That sequencing decision belongs to the prescriber
Diet and Healthy Lifestyle in the Management of Gestational Diabetes Mellitus
Lincoff AM, Brown-Frandsen K, Colhoun HM et al (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes
SUSTAIN 7 was an open-label, parallel-group, phase 3b trial at 194 sites in 16 countries investigating GLP-1R agonists semaglutide and dulaglutide [1]
Physical assessment including current weight, BMI, and any relevant health metrics that inform your treatment plan
Ingredients: Petrolatum, Paraffin Wax, Glycerin, Butyrospermum Parkii (Shea) Butter, Ascorbic Acid (Vitamin C), Hydrogenated Polyisobutene, Caprylic/Capric Triglyceride, Flavor, CI 15850